|
|
Volumn 20, Issue 5-6, 1996, Pages 427-434
|
|
High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia
a
|
|
Author keywords
Acute myeloblastic leukemia; High dose cytarabine; Leukemia; r GCSF; Resistant; Treatment
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
ETOPOSIDE;
IDARUBICIN;
MITOXANTRONE;
PREDNISONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RETINOIC ACID;
TIOGUANINE;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW CELL;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG TOLERANCE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKEMIA REMISSION;
LEUKOCYTE COUNT;
LIVER TOXICITY;
MALE;
NAUSEA;
NEPHROTOXICITY;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
SKIN MANIFESTATION;
STOMATITIS;
THROMBOCYTE COUNT;
VOMITING;
|
|
EID: 0029865008
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428199609052424 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
